| 1 | [SID124966204] | Active | IC50 | 0.00822 | DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) [AID625263, Type: other] | Glucocorticoid receptor [gi:121069] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Active | | IC50 | 0.00822 [uM] | | BioAssay | DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) | | AID | 625263 | | BioAssay type | other | | Target | Glucocorticoid receptor [gi:121069] | | PubMed | | | Data Table |  |
|
| 2 | [SID124966204] | Active | IC50 | 0.00822 | DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) [AID625263, Type: other] | Glucocorticoid receptor [gi:121069] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Active | | IC50 | 0.00822 [uM] | | BioAssay | DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) | | AID | 625263 | | BioAssay type | other | | Target | Glucocorticoid receptor [gi:121069] | | PubMed | | | Data Table |  |
|
| 3 | [SID124966204] | Active | IC50 | 0.00822 | DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) [AID625263, Type: other] | Glucocorticoid receptor [gi:121069] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Active | | IC50 | 0.00822 [uM] | | BioAssay | DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) | | AID | 625263 | | BioAssay type | other | | Target | Glucocorticoid receptor [gi:121069] | | PubMed | | | Data Table |  |
|
| 4 | [SID124966204] | Active | IC50 | 0.00822 | DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) [AID625263, Type: other] | Glucocorticoid receptor [gi:121069] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Active | | IC50 | 0.00822 [uM] | | BioAssay | DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) | | AID | 625263 | | BioAssay type | other | | Target | Glucocorticoid receptor [gi:121069] | | PubMed | | | Data Table |  |
|
| 5 | [SID124966204] | Active | IC50 | 6.429 | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625153, Type: other] | Muscarinic acetylcholine receptor M [gi:113125] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Active | | IC50 | 6.429 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625153 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113125] | | PubMed | | | Data Table |  |
|
| 6 | [SID124966204] | Active | IC50 | 6.429 | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625153, Type: other] | Muscarinic acetylcholine receptor M [gi:113125] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Active | | IC50 | 6.429 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625153 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113125] | | PubMed | | | Data Table |  |
|
| 7 | [SID124966204] | Active | IC50 | 6.429 | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625153, Type: other] | Muscarinic acetylcholine receptor M [gi:113125] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Active | | IC50 | 6.429 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625153 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113125] | | PubMed | | | Data Table |  |
|
| 8 | [SID124966204] | Active | IC50 | 6.429 | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625153, Type: other] | Muscarinic acetylcholine receptor M [gi:113125] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Active | | IC50 | 6.429 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625153 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113125] | | PubMed | | | Data Table |  |
|
| 9 | [SID124966204] | Active | IC50 | 6.429 | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625153, Type: other] | Muscarinic acetylcholine receptor M [gi:113125] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Active | | IC50 | 6.429 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625153 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113125] | | PubMed | | | Data Table |  |
|
| 10 | [SID124966204] | Active | IC50 | 6.959 | DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625151, Type: other] | Muscarinic acetylcholine receptor M [gi:113118] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Active | | IC50 | 6.959 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625151 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113118] | | PubMed | | | Data Table |  |
|
| 11 | [SID124966204] | Active | IC50 | 6.959 | DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625151, Type: other] | Muscarinic acetylcholine receptor M [gi:113118] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Active | | IC50 | 6.959 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625151 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113118] | | PubMed | | | Data Table |  |
|
| 12 | [SID124966204] | Active | IC50 | 7.861 | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625155, Type: other] | Muscarinic acetylcholine receptor M [gi:543761] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Active | | IC50 | 7.861 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625155 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:543761] | | PubMed | | | Data Table |  |
|
| 13 | [SID124966204] | Active | IC50 | 7.861 | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625155, Type: other] | Muscarinic acetylcholine receptor M [gi:543761] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Active | | IC50 | 7.861 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625155 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:543761] | | PubMed | | | Data Table |  |
|
| 14 | [SID124966204] | Active | IC50 | 7.861 | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625155, Type: other] | Muscarinic acetylcholine receptor M [gi:543761] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Active | | IC50 | 7.861 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625155 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:543761] | | PubMed | | | Data Table |  |
|
| 15 | [SID124966204] | Active | IC50 | 7.861 | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625155, Type: other] | Muscarinic acetylcholine receptor M [gi:543761] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Active | | IC50 | 7.861 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625155 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:543761] | | PubMed | | | Data Table |  |
|
| 16 | [SID124966204] | Active | IC50 | 10.06 | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) [AID625269, Type: other] | Histamine H1 receptor [gi:547645] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Active | | IC50 | 10.06 [uM] | | BioAssay | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) | | AID | 625269 | | BioAssay type | other | | Target | Histamine H1 receptor [gi:547645] | | PubMed | | | Data Table |  |
|
| 17 | [SID124966204] | Active | IC50 | 10.06 | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) [AID625269, Type: other] | Histamine H1 receptor [gi:547645] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Active | | IC50 | 10.06 [uM] | | BioAssay | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) | | AID | 625269 | | BioAssay type | other | | Target | Histamine H1 receptor [gi:547645] | | PubMed | | | Data Table |  |
|
| 18 | [SID124966204] | Active | IC50 | 11.924 | DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625154, Type: other] | Muscarinic acetylcholine receptor M [gi:23503039] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Active | | IC50 | 11.924 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625154 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:23503039] | | PubMed | | | Data Table |  |
|
| 19 | [SID124966204] | Active | IC50 | 11.924 | DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625154, Type: other] | Muscarinic acetylcholine receptor M [gi:23503039] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Active | | IC50 | 11.924 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625154 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:23503039] | | PubMed | | | Data Table |  |
|
| 20 | [SID124966204] | Active | IC50 | 11.924 | DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625154, Type: other] | Muscarinic acetylcholine receptor M [gi:23503039] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Active | | IC50 | 11.924 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625154 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:23503039] | | PubMed | | | Data Table |  |
|
| 21 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625152, Type: other] | Muscarinic acetylcholine receptor M [gi:113122] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625152 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113122] | | PubMed | | | Data Table |  |
|
| 22 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625152, Type: other] | Muscarinic acetylcholine receptor M [gi:113122] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625152 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113122] | | PubMed | | | Data Table |  |
|
| 23 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625152, Type: other] | Muscarinic acetylcholine receptor M [gi:113122] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625152 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113122] | | PubMed | | | Data Table |  |
|
| 24 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625152, Type: other] | Muscarinic acetylcholine receptor M [gi:113122] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625152 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113122] | | PubMed | | | Data Table |  |
|
| 25 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625152, Type: other] | Muscarinic acetylcholine receptor M [gi:113122] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625152 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113122] | | PubMed | | | Data Table |  |
|
| 26 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625152, Type: other] | Muscarinic acetylcholine receptor M [gi:113122] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625152 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113122] | | PubMed | | | Data Table |  |
|
| 27 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA) [AID625271, Type: other] | 3-hydroxy-3-methylglutaryl-coenzyme A reductase [gi:123343] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA) | | AID | 625271 | | BioAssay type | other | | Target | 3-hydroxy-3-methylglutaryl-coenzyme A reductase [gi:123343] | | PubMed | | | Data Table |  |
|
| 28 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) [AID625270, Type: other] | Histamine H2 receptor [gi:123120] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) | | AID | 625270 | | BioAssay type | other | | Target | Histamine H2 receptor [gi:123120] | | PubMed | | | Data Table |  |
|
| 29 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) [AID625270, Type: other] | Histamine H2 receptor [gi:123120] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) | | AID | 625270 | | BioAssay type | other | | Target | Histamine H2 receptor [gi:123120] | | PubMed | | | Data Table |  |
|
| 30 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) [AID625270, Type: other] | Histamine H2 receptor [gi:123120] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) | | AID | 625270 | | BioAssay type | other | | Target | Histamine H2 receptor [gi:123120] | | PubMed | | | Data Table |  |
|
| 31 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) [AID625192, Type: other] | 5-hydroxytryptamine receptor 2A [gi:543727] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) | | AID | 625192 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2A [gi:543727] | | PubMed | | | Data Table |  |
|
| 32 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) [AID625192, Type: other] | 5-hydroxytryptamine receptor 2A [gi:543727] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) | | AID | 625192 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2A [gi:543727] | | PubMed | | | Data Table |  |
|
| 33 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) [AID625192, Type: other] | 5-hydroxytryptamine receptor 2A [gi:543727] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) | | AID | 625192 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2A [gi:543727] | | PubMed | | | Data Table |  |
|
| 34 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625217, Type: other] | 5-hydroxytryptamine receptor 2B [gi:1168220] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625217 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2B [gi:1168220] | | PubMed | | | Data Table |  |
|
| 35 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625217, Type: other] | 5-hydroxytryptamine receptor 2B [gi:1168220] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625217 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2B [gi:1168220] | | PubMed | | | Data Table |  |
|
| 36 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625217, Type: other] | 5-hydroxytryptamine receptor 2B [gi:1168220] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625217 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2B [gi:1168220] | | PubMed | | | Data Table |  |
|
| 37 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) [AID625218, Type: other] | 5-hydroxytryptamine receptor 2C [gi:112816] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | | AID | 625218 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2C [gi:112816] | | PubMed | | | Data Table |  |
|
| 38 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) [AID625218, Type: other] | 5-hydroxytryptamine receptor 2C [gi:112816] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | | AID | 625218 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2C [gi:112816] | | PubMed | | | Data Table |  |
|
| 39 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) [AID625218, Type: other] | 5-hydroxytryptamine receptor 2C [gi:112816] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | | AID | 625218 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2C [gi:112816] | | PubMed | | | Data Table |  |
|
| 40 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625221, Type: other] | 5-hydroxytryptamine receptor 6 [gi:1703010] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625221 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 6 [gi:1703010] | | PubMed | | | Data Table |  |
|
| 41 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625221, Type: other] | 5-hydroxytryptamine receptor 6 [gi:1703010] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625221 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 6 [gi:1703010] | | PubMed | | | Data Table |  |
|
| 42 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625221, Type: other] | 5-hydroxytryptamine receptor 6 [gi:1703010] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625221 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 6 [gi:1703010] | | PubMed | | | Data Table |  |
|
| 43 | [SID124966204] | Unspecified | | | DRUGMATRIX: Chemokine CXCR1 (IL-8A) [AID625240, Type: other] | C-X-C chemokine receptor type 1 [gi:108936015] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | BioAssay | DRUGMATRIX: Chemokine CXCR1 (IL-8A) | | AID | 625240 | | BioAssay type | other | | Target | C-X-C chemokine receptor type 1 [gi:108936015] | | PubMed | | | Data Table |  |
|
| 44 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8) [AID625241, Type: other] | C-X-C chemokine receptor type 2 [gi:1352454] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8) | | AID | 625241 | | BioAssay type | other | | Target | C-X-C chemokine receptor type 2 [gi:1352454] | | PubMed | | | Data Table |  |
|
| 45 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) [AID625171, Type: other] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) | | AID | 625171 | | BioAssay type | other | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | | | Data Table |  |
|
| 46 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) [AID625171, Type: other] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) | | AID | 625171 | | BioAssay type | other | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | | | Data Table |  |
|
| 47 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) [AID625171, Type: other] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) | | AID | 625171 | | BioAssay type | other | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | | | Data Table |  |
|
| 48 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) [AID625171, Type: other] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) | | AID | 625171 | | BioAssay type | other | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | | | Data Table |  |
|
| 49 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) [AID625171, Type: other] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) | | AID | 625171 | | BioAssay type | other | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | | | Data Table |  |
|
| 50 | [SID124966204] | Unspecified | IC50 | | DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr)) [AID625187, Type: other] | Tyrosine-protein kinase Lck [gi:125474] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 124966204 | | CID | 107782 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr)) | | AID | 625187 | | BioAssay type | other | | Target | Tyrosine-protein kinase Lck [gi:125474] | | PubMed | | | Data Table |  |
|